Login to Your Account



Other News To Note


Thursday, January 31, 2013

• Pluristem Therapeutics Inc., of Haifa, Israel, said it is moving into its new GMP facility, which allows for the production of mass quantities of PLacental eXpanded cells that possess the advantages of being grown using Pluristem's 3D bioreactor technology.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription